Ohio Public Employees Retirement System (OPERS)’s BioCryst Pharmaceuticals BCRX Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio BCRX Stock Details BCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-22,754	Closed	-$141K	–	2257
2024 Q2	$141K	Buy	+22,754	New	+$126K	﹤0.01%	1399
2023 Q3	–	Sell	-9,678	Closed	-$68K	–	1969
2023 Q2	$68K	Sell	9,678 -46,389	-83%	-$372K	﹤0.01%	1494
2023 Q1	$468K	Hold	56,067	–	–	﹤0.01%	1278
2022 Q4	$644K	Sell	56,067 -3,281	-6%	-$40.9K	﹤0.01%	1247
2022 Q3	$748K	Buy	+59,348	New	+$764K	﹤0.01%	1264
2020 Q1	–	Sell	-76,200	Closed	-$263K	–	1881
2019 Q4	$263K	Hold	76,200	–	–	﹤0.01%	1349
2019 Q3	$218K	Buy	+76,200	New	+$237K	﹤0.01%	1489

Other funds holding BCRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s BCRX Position: Q3 2024 in Review

Ohio Public Employees Retirement System (OPERS) sold out of BioCryst Pharmaceuticals (BCRX) in Q3 2024, closing a stake of 22,754 shares — an estimated $141K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in BCRX in Q3 2019 and held it in 7 quarters. The position peaked at $748K in Q3 2022. 257 funds tracked by Wall St. Rank hold BCRX as of Q3 2024.

Ohio Public Employees Retirement System (OPERS) reported no remaining BioCryst Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
Ohio Public Employees Retirement System (OPERS) sold 22,754 BioCryst Pharmaceuticals shares in Q3 2024, an estimated $141K.
Ohio Public Employees Retirement System (OPERS) first reported a position in BioCryst Pharmaceuticals in Q3 2019 and held it in 7 quarters.
Ohio Public Employees Retirement System (OPERS)'s BioCryst Pharmaceuticals position peaked at $748K in Q3 2022.
257 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q3 2024.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q3 2024, filed 15 Nov 2024.